57 results

• Horizon Therapeutics Acquired for Nearly $30B Amid Growing Threat of Tepezza Lawsuit Payouts

  December 15, 2022

  Irvin Jackson

  Despite the threat of having to eventually pay Tepezza lawsuit payouts, Amgen has acquired the drug's manufacturer, Horizon Pharmaceuticals for nearly $30 billion.

• Tepezza Side Effects May Increase Risk of Hyperglycemia: Study

  November 29, 2022

  Irvin Jackson

  A new study found more than half of patients who took Tepezza experienced some form of hyperglycemia, which could be a particularly serious risk to patients with diabetes.

• Tepezza Users Often Require Second Treatment Course for Thyroid Eye Disease

  November 22, 2022

  Irvin Jackson

  The findings of a new study suggest five percent of Tepezza users require a second treatment course of the thyroid eye disease drug, raising questions as to whether those patients face an even higher risk of hearing loss than other Tepezza users.

• Side Effects of Tepezza Caused Irreversible Hearing Loss, Lawsuit Alleges

  November 18, 2022

  Irvin Jackson

  A product liability lawsuit claims the side effects of Tepezza, a thyroid eye disease drug, led to permanent hearing loss.

• Study Highlights Link Between Tepezza and Hearing Problems After Four Injections of the Thyroid Eye Disease Drug

  November 7, 2022

  Irvin Jackson

  A new study finds that most Tepezza patients suffer some degree of hearing loss, and a third of those may not recover their hearing.

• Tepezza Lawsuit Alleges Infusion Side Effects Caused Hearing Loss, Tinnitus

  October 31, 2022

  Irvin Jackson

  The manufacturers of the thyroid eye disease drug Tepezza are calling for a lawsuit over hearing loss complications to be dismissed due to federal preemption laws.

• Tepezza Side Effects May Be Linked To Hearing Loss: Study

  March 26, 2021

  Irvin Jackson

  The new thyroid eye disease drug, Tepezza, is linked to an increased risk of hearing problems, according to the findings of a new study.